Chemren Bio-Engineering Co., Ltd.

Product name : TAK-901
Item : CR1027
CAS : 934541-31-8
 Enlarge Image                   Back

Description of:TAK-901
After binding of TAK-901 to Aurora B, it inhibits the activity of Aurora B, which may result in a reduction in the proliferation of tumor cells that overexpress Aurora B. TAK-901 is originally developed by Millennium Pharmaceuticals, Inc..

Theoretical analysis:TAK-901
M.Wt: 504.64
Formula: C28H32N4O3S
Solubility: Unknown
Purity: >98%
Storage: at -20℃ 2 years
CAS No: 934541-31-8

Availability and price:
We offer significant discount for larger quantity order.
For quotation, question, and order, please send email to :

Quality control data:
Quality Control by H-NMR,C-NMR,LC-MS,HPLC.
Product will be shipped with supporting analytical data.
Fast delivery about 4-5 working days

Related Products :

Online service